Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Advanz Hits Back Over £100m+ Fines For UK Liothyronine Pricing
Firm ‘Utterly Disagrees’ With CMA And Vows To Appeal Decision
Jul 29 2021
•
By
David Wallace
The CMA announced fines of more than £100m over liothyronine pricing • Source: Alamy
More from Drug Pricing
More from Policy & Regulation